| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 9 | |
| #2 | Canada | 8 | |
| #3 | Australia | 7 | |
| #4 | EPO (European Patent Office) | 5 | |
| #5 | Israel | 5 | |
| #6 | Mexico | 4 | |
| #7 | United States | 4 | |
| #8 | China | 3 | |
| #9 | Norway | 3 | |
| #10 | Brazil | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Organic fine chemistry | |
| #5 | Measurement | |
| #6 | Machines | |
| #7 | Agriculture |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gervais Francine | 31 |
| #2 | Kong Xianqi | 16 |
| #3 | Chalifour Robert | 16 |
| #4 | Green Allan M | 9 |
| #5 | Migneault David | 8 |
| #6 | Gupta Ajay | 6 |
| #7 | Hebert Lise | 5 |
| #8 | Chalifour Robert J | 5 |
| #9 | Kisilevsky Robert | 5 |
| #10 | Morissette Celine | 4 |
| Publication | Filing date | Title |
|---|---|---|
| CA2416617A1 | Amyloid targeting imaging agents and uses thereof | |
| CA2388092A1 | Stereoselective antifibrillogenic peptides and peptidomimetics thereof | |
| WO0027807A1 | Polymorphic forms of an amyloidosis inhibitor and methods of preparation | |
| EP1077690A1 | Use of amyloid inhibitors for modulating neuronal cell death | |
| US6329356B1 | Phosphono-carboxylate compounds for treating amyloidosis | |
| US5858326A | Methods of increasing amyloid deposition |